Laughter Therapy For COPD
Laughter therapy may help people with chronic lung disease breathe easier
Introduction To Laughter Therapy
Laughter therapy, a low-cost treatment option, has been linked to improvements in various conditions, including diabetes, kidney failure, and cancer. Recently, researchers have explored its potential benefits for people with chronic obstructive pulmonary disease (COPD), a leading cause of disability and death worldwide. COPD affects millions of people, causing breathlessness even during simple daily activities due to the inability to fully expel air from the lungs.
Understanding Chronic Obstructive Pulmonary Disease
COPD is characterized by the inability to fully expel air from the lungs, resulting in stale air remaining trapped inside. This condition is typically treated with medications such as bronchodilators and corticosteroids, as well as specialized breathing exercises like pursed-lip breathing. Despite these treatments, many people with COPD become increasingly dependent on others for care, reducing their quality of life. Researchers have been seeking alternative therapies to improve the lives of those affected by COPD.
Laughter Therapy Trial
A recent randomized controlled trial, conducted by Goncagul Aldan and her colleagues, investigated the effects of laughter therapy on people with COPD. The trial involved 63 participants, divided into three groups: one group performed pursed-lip breathing exercises, another received laughter therapy, and the third group served as a control. The laughter therapy program included playful exercises like mimicking sounds, rhythmic clapping, and relaxation techniques. Participants were coached by laughter therapists and instructed to perform the techniques on their own for 30 minutes, three times a week, over an eight-week period.
Key Findings And Implications
After eight weeks, participants in the laughter therapy and pursed-lip breathing groups showed significant improvements in breathing difficulty and overall health compared to the control group. These benefits persisted even a month after the trial ended. While the therapies did not reduce the need for daily assistance from caregivers, the results suggest that laughter therapy may be a valuable addition to existing treatments for COPD. The researchers propose that laughter therapy may exercise the breathing muscles, promote deeper exhalation, improve lymphatic flow, and trigger the release of endorphins, while also lowering stress hormone levels.
Future Outlook And Potential Benefits
The study's findings are promising, and further research could help clarify the mechanisms by which laughter therapy improves COPD symptoms. Laughter therapy is distinct from intense or unguided laughter, which can have adverse effects. The structured approach of laughter therapy may provide a safe and enjoyable way to reduce anxiety and support emotional wellbeing. As a low-cost treatment option, laughter therapy has the potential to improve the lives of people with COPD, and its applications may extend to other conditions as well.
Sources
This is an original synthesis by Qivorane based on reporting from the outlets below.